Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reconsideration of Antinucleocapsid IgG Antibody as a Marker of SARS-CoV-2 Infection Postvaccination for Mild COVID-19 Patients
Santosh Dhakal, Tong Yu, Anna Yin, et al.
Open Forum Infectious Diseases (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

COVID-19 vaccination induces distinct T-cell responses in pediatric solid organ transplant recipients and immunocompetent children
Katerina Roznik, Jiashu Xue, Georgia Stavrakis, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Characterising the SARS-CoV-2 nucleocapsid (N) protein antibody response
Charles O. Noble, Ellie McDonald, Suellen Nicholson, et al.
Journal of Infection (2025), pp. 106436-106436
Open Access
Longitudinal analysis of antibody titers after primary and booster mRNA COVID-19 vaccination can identify individuals at risk for breakthrough infection
Hyeongki Park, Naotoshi Nakamura, Shô Miyamoto, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Combined anti-S1 and anti-S2 antibodies from hybrid immunity elicit potent cross-variant ADCC against SARS-CoV-2
Michael D. Grant, Kirsten Bentley, Ceri A. Fielding, et al.
JCI Insight (2023) Vol. 8, Iss. 15
Open Access | Times Cited: 13
Anti-nucleocapsid antibody levels following initial and repeat SARS-CoV-2 infections in a cohort of long-term care facility residents in England (VIVALDI)
Oliver Stirrup, Gokhan Tut, Maria Krutikov, et al.
Wellcome Open Research (2024) Vol. 9, pp. 45-45
Open Access | Times Cited: 4
Bivalent mRNA COVID vaccines elicit predominantly cross-reactive CD4+ T cell clonotypes
Joel Sop, Caroline C. Traut, Arbor G. Dykema, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 3, pp. 101442-101442
Open Access | Times Cited: 2
SARS‐CoV‐2 immunoassays in a predominantly vaccinated population: Performances and qualitative agreements obtained with two analytical approaches and four immunoassays
Christian Renaud, Antoine Lewin, Yves Grégoire, et al.
Vox Sanguinis (2024) Vol. 119, Iss. 6, pp. 533-540
Closed Access | Times Cited: 2
Detection of Nucleocapsid Antibodies Associated with Primary SARS-CoV-2 Infection in Unvaccinated and Vaccinated Blood Donors
Eduard Grebe, Mars Stone, Bryan R. Spencer, et al.
Emerging infectious diseases (2024) Vol. 30, Iss. 8, pp. 1621-1630
Open Access | Times Cited: 2
Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary Omicron infection in children and hybrid immunity in adults
Gro Tunheim, Even Fossum, Anna Hayman Robertson, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Performance of SARS COV-2 IgG Anti-N as an Independent Marker of Exposure to SARS COV-2 in an Unvaccinated West African Population
Adam Abdullahi, James Opoku Frimpong, Mark T. K. Cheng, et al.
American Journal of Tropical Medicine and Hygiene (2023) Vol. 109, Iss. 4, pp. 890-894
Open Access | Times Cited: 6
Persistent humoral immune response in youth throughout the COVID-19 pandemic: prospective school-based cohort study
Alessia Raineri, Thomas Radtke, Sonja Rueegg, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 5
The Long-Term Immunogenicity of mRNABNT162b Third Vaccine Dose in Solid Organ Transplant Recipients
Maria Antonella Zingaropoli, Mariasilvia Guardiani, Federica Dominelli, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 224-224
Open Access | Times Cited: 1
Detection of anti-nucleocapsid antibodies associated with primary SARS-CoV-2 infection in unvaccinated and vaccinated blood donors
Eduard Grebe, Mars Stone, Bryan R. Spencer, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Primary series COVID-19 vaccine effectiveness among health care workers in the country of Georgia, March–December 2021
Mark A. Katz, Madelyn Yiseth Rojas Castro, Giorgi Chakhunashvili, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0307805-e0307805
Open Access | Times Cited: 1
Application of machine learning algorithms to identify serological predictors of COVID-19 severity and outcomes
Santosh Dhakal, Anna Yin, Marta Escarra‐Senmarti, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 1
Antibody response in elderly vaccinated four times with an mRNA anti-COVID-19 vaccine
Alexander Rouvinski, Ahuva Friedman, Saveliy Kirillov, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Hybrid immunity elicits potent cross-variant ADCC against SARS-CoV-2 through a combination of anti-S1 and S2 antibodies
Michael D. Grant, Kirsten Bentley, Ceri A. Fielding, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Are anti-SARS-CoV-2 S/N IgG/IgM antibodies always predictive of previous SARS-CoV-2 infection?
Giuseppe Lippi, Brandon Michael Henry, Laura Pighi, et al.
Advances in Laboratory Medicine / Avances en Medicina de Laboratorio (2023) Vol. 4, Iss. 2, pp. 175-179
Open Access | Times Cited: 2
Primary Series COVID-19 Vaccine Effectiveness among Health Care Workers in the Country of Georgia, March–December 2021
Mark A. Katz, Madelyn Yiseth Rojas Castro, Giorgi Chakhunashvili, et al.
(2023)
Open Access | Times Cited: 2
Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adults
Denis Nash, Avantika Srivastava, Yanhan Shen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Enhanced immunity against SARS-CoV-2 in returning Chinese individuals
Runyu Yuan, Huimin Chen, Lina Yi, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
Humoral Response Following 3 Doses of mRNA COVID-19 Vaccines in Patients With Non-Dialysis-Dependent CKD: An Observational Study
Omosomi Enilama, Kevin Yau, Lee Er, et al.
Canadian Journal of Kidney Health and Disease (2024) Vol. 11
Open Access
SARS-CoV-2 antibody prevalence by industry, workplace characteristics, and workplace infection prevention and control measures, North Carolina, 2021 to 2022
Carolyn Gigot, Nora Pisanic, Kristoffer Spicer, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Prevalence of SARS-CoV-2-specific antibodies in a sample of the Lithuanian population-based study in Spring 2023
Martynas Simanavičius, Indrė Kučinskaitė-Kodzė, Snieguolė Kaselienė, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e29343-e29343
Open Access
Anti-SARS-CoV-2 Nucleocapsid Antibody Positivity Three Years after COVID-19
Chang Kyung Kang, Young-Ju Kim, Hyeon Jae Jo, et al.
Japanese Journal of Infectious Diseases (2024) Vol. 77, Iss. 5, pp. 285-288
Open Access
Page 1 - Next Page

Scroll to top